← Open Payments lookup

NASIM TASHAKKOR: Open Payments

NPI 1164990453 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$661 in 25 payments from 6 companies in 2025. Trend: 2023 $14 · 2024 $433 · 2025 $661

Food & beverage: $661
CompanyPaymentsAmount
Alkermes, Inc.7$249
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$138
Teva Pharmaceuticals USA, Inc.7$135
Janssen Pharmaceuticals, Inc3$65
E.R. Squibb & Sons, L.L.C.2$59
Otsuka America Pharmaceutical, Inc.1$15

Products named: CAPLYTA, ARISTADA, LYBALVI, AUSTEDO XR, INVEGA SUSTENNA, COBENFY, UZEDY, ABILIFY ASIMTUFII.

Industry payments across WA — which companies pay providers there.